High-dose aspirin is required to influence plasma fibrin network structure in patients with type 1 diabetes

Diabetes Care

Volumn 35, Issue 2, 2012, Pages 404-408

  Tehrani, Sara ^a   Antovic, Aleksandra ^a   Mobarrez, Fariborz ^a   Mageed, Koteiba ^a   Lins, Per Eric ^a   Adamson, Ulf ^a   Wallén, Håkan N ^a   Jörneskog, Gun ^a  

^a DANDERYD HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; FIBRIN; HEMOGLOBIN A1C; TROMBYL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG DOSE COMPARISON; DRUG MEGADOSE; FEMALE; FIBRIN NETWORK PERMEABILITY; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PATIENT COMPLIANCE; PERMEABILITY; PERMEABILITY COEFFICIENT; PLASMA FIBRIN NETWORK; PLATELET MICROPARTICLE; PROTEIN BLOOD LEVEL; PROTEIN STRUCTURE; SWEDEN;

ASPIRIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, TYPE 1; DRUG ADMINISTRATION SCHEDULE; FEMALE; FIBRIN; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE;

EID: 84859079192     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-1302     Document Type: Article

References (25)

1. Yngen M, Östenson CG, Hu H, Li N, Hjemdahl P, Wallén NH. Enhanced P-selectin expression and increased soluble CD40 ligand in patients with type 1 diabetes mellitus and microangiopathy: evidence for platelet hyperactivity and chronic inflammation. Diabetologia 2004;47:537-540 (Pubitemid 38491251)
2. Ganda OP, Arkin CF. Hyperfibrinogenemia: animportant risk factor for vascular complications in diabetes. Diabetes Care 1992;15:1245-1250
3. Dunn EJ, Philippou H, Ariëns RA, Grant PJ.Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus. Diabetologia 2006;49:1071-1080
4. Nomura S, Suzuki M, Katsura K, et al. Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus. Atherosclerosis 1995;116:235-240
5. Cubbon RM, Gale CP, Rajwani A, et al. Aspirin and mortality inpatients with diabetes sustaining acute coronary syndrome. Diabetes Care 2008;31:363-365 (Pubitemid 351213352)
6. Undas A, Brummel-Ziedins KE, Mann KG. Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly anti-platelet actions. Blood 2007;109:2285-2292 (Pubitemid 46425865)
7. Collet JP, Allali Y, Lesty C, et al. Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis. Arterioscler Thromb Vasc Biol 2006;26:2567-2573 (Pubitemid 44607482)
8. Collet JP, Park D, Lesty C, et al. Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy. Arterioscler Thromb Vasc Biol 2000;20:1354-1361 (Pubitemid 30262939)
9. Rooth E, Wallen NH, Blombäck M, He S. Decreased fibrin network permeability and impaired fibrinolysis in the acute and convalescent phase of ischemic stroke. Thromb Res 2011;127:51-56
10. Colle JP, Mishal Z, Lesty C, et al. Abnormal fibrin clot architecture in nephrotic patients is related to hypofibrinolysis: influence of plasma biochemical modifications: a possible mechanism for the high thrombotic tendency? Thromb Haemost 1999;82:1482-1489 (Pubitemid 29527643)
11. Jörneskog G, Egberg N, Fagrell B, et al. Altered properties of the fibrin gel structure in patients with IDDM. Diabetologia 1996;39:1519-1523 (Pubitemid 26397359)
12. Jörneskog G, Hansson LO, Wallen NH, Yngen M, Blombäck M. Increased plasma fibrin gel porosity in patients with type I diabetes during continuous subcutaneous insulin infusion. J Thromb Haemost 2003;1:1195-1201
13. Lütjens A, te Velde AA, vd Veen EA, vdMeer J. Glycosylation of human fibrinogen in vivo. Diabetologia 1985;28:87-89
14. Ardawi MS, Nasrat HN, Mira SA, Fatani HH. Comparison of glycosylated fibrinogen, albumin, and haemoglobin as indices of blood glucose control in diabetic patients. Diabet Med 1990;7:819-824 (Pubitemid 20370111)
15. Antovic A, Perneby C, Ekman GJ, et al. Marked increase of fibrin gel permeability with very low dose ASA treatment. Thromb Res 2005;116:509-517 (Pubitemid 41330816)
16. Williams S, Fatah K, Hjemdahl P, Blombäck M. Better increase infibrin gel porosity by low dose than intermediate dose acetylsalicylic acid. Eur Heart J 1998;19:1666-1672 (Pubitemid 28524185)
17. Björnsson TD, Schneider DE, Berger H Jr. Aspirin acetylates fibrinogen and enhances fibrinolysis: fibrinolytic effect is independent of changes in plasminogen activator levels. J Pharmacol Exp Ther 1989;250:154-161 (Pubitemid 19194985)
18. Tehrani S, Mobarrez F, Antovic A, et al. Atorvastatin has antithrombotic effects in patients with type 1 diabetes and dyslipidemia. Thromb Res 2010;126:e225-e231
19. Siljander P, Carpen O, Lassila R. Platelet-derived microparticles associate with fibrin during thrombosis. Blood 1996;87:4651-4663 (Pubitemid 26162364)
20. He S, Cao H, Antovic A, Blombäck M. Modifications of flow measurement to determine fibrin gel permeability and the preliminary use in research and clinical materials. Blood Coagul Fibrinolysis 2005;16:61-67
21. Mobarrez F, Antovic J, Egberg N, et al. A multicolor flow cytometric assay for measurement of platelet-derived microparticles. Thromb Res 2010;125:e110-e116
22. Kalani M, Silveira A, Blombäck M, et al. Beneficial effects of dalteparin on haemostatic function and local tissue oxygenation in patients with diabetes, severe vascular disease and foot ulcers. Thromb Res 2007;120:653-661 (Pubitemid 47268041)
23. Watala C, Pluta J, Golanski J, et al. Increased protein glycation indiabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin. J Mol Med (Berl) 2005;83:148-158 (Pubitemid 40379303)
24. Garlick RL, Mazer JS. The principal site of nonenzymatic glycosylation of human serum albumin in vivo. J Biol Chem 1983;258:6142-6146 (Pubitemid 13106789)
25. Ernst E, Resch KL. Fibrinogen as acardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med 1993;118:956-963 (Pubitemid 23164134)